NovaBridge Biosciences (NBP) stock
NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.82+0.03 (+3.89%)
Close on Nov 17, 2026Market cap $94.88MP/E –Yield –
NovaBridge Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
NovaBridge Biosciences's enterprise value was $99.34M on Nov 11, 2026, against $312.96M a year earlier. Over the last 5 years it ranged from -$360.64M to $2.65B, with a median of -$59.93M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $99.34M | -69.4% |
| 2025 | Dec 31, 2025 | $324.37M | – |
| 2024 | Dec 31, 2024 | -$240.30M | – |
| 2023 | Dec 29, 2023 | -$325.49M | – |
| 2022 | Dec 30, 2022 | -$221.30M | -108.4% |
| 2021 | Dec 31, 2021 | $2.65B | -1.6% |
| 2020 | Dec 31, 2020 | $2.69B | – |
See a number that looks wrong?